Related Experiment Video
Updated: May 6, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Metataxonomic and Immunological Analysis of Feces from Children with or without Phelan-McDermid Syndrome
Claudio Alba1,2, Carmen Herranz1,2, Miguel A Monroy3
1Department Nutrition and Food Science, Complutense University of Madrid, 28040 Madrid, Spain.
Insights
Children with Phelan-McDermid syndrome (PMS) show altered gut bacteria and reduced short-chain fatty acids (SCFAs). These gut microbiome changes may influence neurodevelopmental and gastrointestinal symptoms in PMS.
Area of Science:
- Neuroscience
- Microbiology
- Genetics
Background:
- Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder.
- Gut microbiota alterations are increasingly linked to neuropsychiatric conditions.
Purpose of the Study:
- To investigate gut microbiota and immune profiles in children with PMS.
- To compare these profiles against healthy controls.
Main Methods:
- 16S rRNA gene sequencing for bacterial composition analysis.
- Gas chromatography for short-chain fatty acid (SCFA) quantification.
- Multiplex cytokine assay for immunological profiling.
Main Results:
- Distinct gut microbiota composition in PMS patients, with lower abundance of *Faecalibacterium* and *Agathobacter*.
- Reduced SCFA levels observed in children with PMS.
- Tendency towards higher pro-inflammatory cytokines in PMS group, though not statistically significant.
Conclusions:
- Children with PMS exhibit unique gut microbiota and SCFA profiles.
- These gut alterations may contribute to PMS symptoms.
- Potential for microbiota-targeted therapies in Phelan-McDermid syndrome.
Abstract:
Phelan-McDermid syndrome (PMS) is a neurodevelopmental disorder characterized by a developmental delay and autism spectrum disorder (ASD)-like behaviors. Emerging research suggests a link between gut microbiota and neuropsychiatric conditions, including PMS. This study aimed to investigate the fecal microbiota and immune profiles of children with PMS compared to healthy controls. Fecal samples were collected from children diagnosed with PMS and age-matched healthy controls. The bacterial composition was analyzed using 16S rRNA gene sequencing, while short-chain fatty acids (SCFAs) were quantified through gas chromatography. Immunological profiling was conducted using a multiplex cytokine assay. Significant differences were observed in the gut microbiota composition between PMS patients and controls, including a lower abundance of key bacterial genera such as Faecalibacterium and Agathobacter in PMS patients. SCFA levels were also reduced in PMS patients. Immunological analysis revealed higher levels of several pro-inflammatory cytokines in the PMS group, although these differences were not statistically significant. The findings indicate that children with PMS have distinct gut microbiota and SCFA profiles, which may contribute to the gastrointestinal and neurodevelopmental symptoms observed in this syndrome. These results suggest potential avenues for microbiota-targeted therapies in PMS.

